MapLight Therapeutics, Inc. (MPLT)
NASDAQ: MPLT · Real-Time Price · USD
18.49
+0.15 (0.82%)
At close: Dec 5, 2025, 4:00 PM EST
18.62
+0.13 (0.70%)
After-hours: Dec 5, 2025, 7:42 PM EST

MapLight Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22
Net Income
-102.83-77.58-55.71-30.02
Depreciation & Amortization
0.630.70.560.57
Loss (Gain) From Sale of Assets
0.070.06--
Loss (Gain) From Sale of Investments
-1.07-1.740.51-0.8
Loss (Gain) on Equity Investments
-0.99-0.99-
Stock-Based Compensation
0.71.081.051.36
Other Operating Activities
1.350.750.530.57
Change in Accounts Payable
0.33-1.35-0.411.33
Change in Unearned Revenue
-2.03-0.96-1.661.86
Change in Other Net Operating Assets
-9.94-0.764.11-1.46
Operating Cash Flow
-112.8-78.82-52.01-26.58
Capital Expenditures
-0.2-0.77-0.46-0.75
Investment in Securities
-48.06-80.02--
Investing Cash Flow
-48.26-80.79-0.46-0.75
Issuance of Common Stock
0.130.290.040.01
Other Financing Activities
-1.14-2.19--0.02
Financing Cash Flow
197.86118.06104.5733.18
Net Cash Flow
36.8-41.5452.15.85
Free Cash Flow
-113-79.59-52.47-27.32
Free Cash Flow Per Share
-146.95-108.10-79.54-49.05
Levered Free Cash Flow
--51.86-32.18-
Unlevered Free Cash Flow
--51.86-32.18-
Change in Working Capital
-11.64-3.072.041.72
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q